Irras Ab
Medical Devices, Vasagatan 16, Stockholm, Stockholm, 111, Sweden, 11-50 Employees
Phone Number: +31*********
Who is IRRAS AB
Founded in Sweden in 2012, IRRAS is a commercial medical device company, focused on designing, developing, and commercializing innovative solutions that transform fluid management after s...
Read More
-
Headquarters: Vasagatan 16, Stockholm, Stockholm, 111, Sweden
-
Date Founded: 2011
-
Employees: 11-50
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Medical Devices
SIC Code: 3841
|
NAICS Code: 339112 |
Show More
IRRAS AB Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding IRRAS AB
Answer: IRRAS AB's phone number is +31*********
Answer: IRRAS AB's official website is https://irras.com
Answer: IRRAS AB's revenue is $25 Million to $50 Million
Answer: IRRAS AB's SIC: 3841
Answer: IRRAS AB's NAICS: 339112
Answer: IRRAS AB has 11-50 employees
Answer: IRRAS AB is in Medical Devices
Answer: IRRAS AB contact info: Phone number: +31********* Website: https://irras.com
Answer: Founded in Sweden in 2012, IRRAS is a commercial medical device company, focused on designing, developing, and commercializing innovative solutions that transform fluid management after surgical procedures. Our initial clinical focus is on intracranial procedures, where excess cerebrospinal fluid (CSF) often needs to be drained and intracranial pressure (ICP) needs to be closely regulated. IRRAS first commercial product, IRRAflow, is a next generation intracranial fluid exchange system that consists of a patented dual lumen catheter and control unit with proprietary software that work together to manage the drainage of excess fluid, intelligently manage the regulation of the patients ICP, and, on a regular basis, proactively flush the catheter to prevent occlusions from forming. These catheter blockages occur up to 40% of the time with legacy drainage systems and can result in inefficient drainage and excessively high infection rates, and IRRAflows intelligent fluid exchange helps to address these shortcomings and provide a new standard of care for how Neuro ICU patients are managed. Through continued technological advances, we remain focused on developing innovative features for IRRAflow as well as new products based on our core fluid exchange technologies. In the future, we envision new therapeutic applications for the IRRAflow platform, including targeted drug delivery and drainage in other clinical areas, such as abdominal surgery. IRRAS is traded on the NASDAQ First North Premier exchange in Stockholm under the symbol IRRAS and is headquartered in Stockholm, Sweden, with offices in Munich, Germany, and San Diego, California.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Powered by
Sign in to CIENCE GO Data to uncover contact details
Free credits every month